Your browser doesn't support javascript.
loading
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Moreno, Carol; Greil, Richard; Demirkan, Fatih; Tedeschi, Alessandra; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Novak, Jan; Strugov, Vladimir; Gill, Devinder; Gribben, John G; Kwei, Kevin; Dai, Sandra; Hsu, Emily; Dean, James P; Flinn, Ian W.
Afiliación
  • Moreno C; Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain. cmorenoa@santpau.cat.
  • Greil R; 3rd Medical Department, Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT, Salzburg, Austria.
  • Demirkan F; Dokuz Eylul University, Division of Hematology, Izmir, Turkey.
  • Tedeschi A; Niguarda Ca' Granda Hospital, Milan, Italy.
  • Anz B; Tennessee Oncology, Chattanooga, TN, USA.
  • Larratt L; University of Alberta Hospital, Edmonton, Alberta, Canada.
  • Simkovic M; Department of Internal Medicine, Haematology, University Hospital and Medical School Hradec, Králové, Czech Republic.
  • Novak J; University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Strugov V; Almazov National Medical Research Centre, St. Petersburg, Russia.
  • Gill D; Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Gribben JG; Barts Cancer Institute, London, United Kingdom.
  • Kwei K; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Dai S; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Hsu E; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Dean JP; Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Flinn IW; Sarah Cannon Research Institute, Nashville, TN, USA.
Haematologica ; 107(9): 2108-2120, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35021599
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Clorambucilo Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Clorambucilo Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2022 Tipo del documento: Article País de afiliación: España